Home
Magna Scientia Advanced Biology and Pharmacy
Peer-Reviewed • ISSN: 2582-8363 • Fast-Track Publishing • Impact Factor 8.6 • Low Publication Charges • Crossref DOI Linking

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September - October 2026 (Volume 19, Issue 1) Submit manuscript

Autoimmune diseases in children and anesthesia

Breadcrumb

  • Home
  • Autoimmune diseases in children and anesthesia

Maria I Dalamagka *

Department of Anesthesiology, General Hospital of Larisa, Greece.
Review Article
Magna Scientia Advanced Biology and Pharmacy, 2025, 14(01), 045-052
Article DOI: 10.30574/msabp.2025.14.1.0022
DOI url: https://doi.org/10.30574/msabp.2025.14.1.0022
Received on 26 December 2024; revised on 13 February 2025; accepted on 16 February 2025
Autoimmune diseases in children may be linked to genetic, environmental, and hormonal factors. It’s estimated that 5% of children worldwide have at least one autoimmune condition, with many experiencing multiple autoimmune challenges. Around 80 autoimmune diseases are present. However, autoimmune diseases in children are rare. When they occur they can be challenging to diagnose and difficult to treat. Advances in our knowledge of the immune system are uncovering connections between inflammation and many different diseases. All autoimmune diseases have relapsing and remitting tendencies. Autoimmune diseases can affect almost any part of the body, though they often target connective tissues (skin, muscle and joints). Symptoms can range from fatigue and mild rashes to rare, serious side effects, like seizures. Diagnosis can be difficult, because many symptoms tend to come and go and are frequently nonspecific. They occur in different kinds of autoimmune diseases as well as other types of illnesses, like infection and cancer. Autoimmune diseases occur most often in females by a 3-to-1 margin over males. Organ-specific disorders (also called localized) focus on one organ or a specific type of tissue: Addison's disease affects the adrenal glands; Autoimmune hepatitis affects the liver; Crohn's disease affects the gastrointestinal tract; Multiple sclerosis (MS) affects the central nervous system; Type 1 diabetes affects the pancreas; Ulcerative colitis affects the gastrointestinal tract. Non-organ-specific disorders (also called systemic) cause problems throughout the body: Juvenile dermatomyositis affects the skin and muscles; Juvenile idiopathic arthritis affects the joints and sometimes the skin and lungs; Lupus affects the joints, skin, liver, kidneys, heart, brain, and other organs; Scleroderma affects the skin, joints, intestine, and sometimes the lungs. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are rare neurobehavioral disorders in children. Affected children may have a diverse array of perioperative manifestations including compulsive behavior, agitation, and abnormal movements. Intravenous anesthetics have anti-inflammatory properties, which in most septic cases are useful for patients. The anti-inflammatory effects of ketamine may be related to the suppression of TNF production by macrophage in the presence of bacteria. Propofol inhibits the phagocytosis and chemotaxis of human monocytes through GABAA receptors. Inhalational anesthetics, in a dose-dependent manner, suppress cytokine release, reduces lymphocyte proliferation, induce apoptosis of the lymphocytes, and inhibits the function of neutrophils. lnhalational anesthetics influence the endocrine response from the hypothalamus-pituitary-adrenal axis and indirectly through the secretions of hormones, such as glucocorticoids and catecholamines. Long-term administration of general anesthesia drugs, due to their effects on cytokines, can lead to disease progression in patients with immune deficiency.
Autoimmune diseases; General anesthesia; Children; Immune system; PANDAS; OCDa
https://msabp.magnascientiapub.com/sites/default/files/fulltext_pdf/MSABP-2025-…

Preview Article PDF

Maria I Dalamagka. Autoimmune diseases in children and anesthesia. Magna Scientia Advanced Biology and Pharmacy, 2025, 14(1), 045-052. Article DOI: https://doi.org/10.30574/msabp.2025.14.1.0022

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 Magna Scientia Advanced Biology and Pharmacy - All rights reserved

Developed & Designed by VS Infosolution